Home

vákuum Sudan komentár adalimumab laser treatment Nad hlavou a plecom škvrna utrpenie

A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis | SpringerLink
A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis | SpringerLink

Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. | Semantic Scholar
Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. | Semantic Scholar

Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library

Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab
Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab

Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 | Scientific Reports
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 | Scientific Reports

AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Amgen Allowing Commercialization Of AMGEVITA™ - iData Research
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Amgen Allowing Commercialization Of AMGEVITA™ - iData Research

Annular Elastolytic Giant Cell Granuloma Successfully Treated With Adalimumab Subsequently Complicated by Drug-Induced Lupus - JDDonline - Journal of Drugs in Dermatology
Annular Elastolytic Giant Cell Granuloma Successfully Treated With Adalimumab Subsequently Complicated by Drug-Induced Lupus - JDDonline - Journal of Drugs in Dermatology

An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab | BMJ Case Reports
An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab | BMJ Case Reports

Dermatologic Therapy: Vol 33, No 3
Dermatologic Therapy: Vol 33, No 3

View Image
View Image

Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet

Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic
Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic

HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data

Cureus | Erythema Dyschromicum Perstans After Adalimumab Treatment
Cureus | Erythema Dyschromicum Perstans After Adalimumab Treatment

Adalimumab Effective in Pediatric Plaque Psoriasis | RheumNow
Adalimumab Effective in Pediatric Plaque Psoriasis | RheumNow

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis | Nature Communications
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis | Nature Communications

Guselkumab Effective for Treatment of Moderate-to-Severe Plaque Psoriasis
Guselkumab Effective for Treatment of Moderate-to-Severe Plaque Psoriasis

AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research

Treatment of Hidradenitis Suppurativa in 2021 & Beyond - Next Steps in Dermatology
Treatment of Hidradenitis Suppurativa in 2021 & Beyond - Next Steps in Dermatology

PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar
PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar

Phototherapy remains a valuable psoriasis treatment
Phototherapy remains a valuable psoriasis treatment

Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences

Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab | Semantic Scholar
Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab | Semantic Scholar

Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial - The Lancet Rheumatology
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial - The Lancet Rheumatology